RxDoctor Payments Data

Karla Olmedo Gutierrez, MD

Medical Oncology · Long Beach, CANPI 1407210891

Payments from drug & device makers

No general payments reported

No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.

How this compares

$0 in reported general payments places this provider in the 0th percentile of 379 medical oncology providers in California.

See all medical oncology providers in California

Medicare billing

Part B allowed, 2024
$3,798,586
Medicare patients
323
Services billed
120,089

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XtandiEnzalutamide17$226,280
Abiraterone Acetate32$66,080
EliquisApixaban18$15,900
XareltoRivaroxaban13$10,724
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen32$820
Anastrozole20$509
Mirtazapine12$327
Ondansetron Hcl11$223
Prednisone37$170
Ondansetron OdtOndansetron11$105
Gabapentin14$101

Paid to pharmacies, not to this prescriber.

Other medical oncology in Long Beach

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →